Antisedan 5 mg/ml Solution injectable
Antisedan 5 mg/ml Solution injectable
Authorised
- Atipamezole hydrochloride
Product identification
Medicine name:
Antisedan 5 mg/ml Solution injectable
Antisedan 5 mg/ml Injektionslösung
Active substance:
- Atipamezole hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Atipamezole hydrochloride5.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Dog
-
Cat
-
-
Subcutaneous use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QV03AB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Antisedan 5 ml Vial Solution for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Orion Corporation
Marketing authorisation date:
Manufacturing sites for batch release:
- Orion Corporation
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 225/92/02/0028
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/03/2023
How useful was this page?:
